You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 1, January 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Efficacy of Ipecac and Activated Charcoal/Cathartic

Prevention of Salicylate Absorption in a Simulated Overdose

Robert A. Curtis, PharmD; Joseph Barone, PharmD; Nicola Giacona, PharmD

Arch Intern Med. 1984;144(1):48-52.


Abstract

• Twelve adult volunteers were given 24 81-mg aspirin tablets and were randomly assigned into the following treatment groups: (1) control aspirin, (2) 30 mL of ipecac repeated if vomiting not induced, (3) 60 g of activated charcoal per 15 g of magnesium sulfate (MgSO4), and (4) ipecac repeated if needed, followed by activated charcoal/MgSO4 given 11/2 hours after the last vomiting episode. All treatments began 60 minutes following aspirin ingestion. Urine was collected for 48 hours for percent total salicylate excretion. Mean SD recovery of salicylate from urine was as follows: aspirin, 96.3% ±7.5%; ipecac 70.3%±11.8%, activated charcoal/MgSO4, 56.4%±12%; and ipecac and activated charcoal/MgSO4, 72.4%± 14.1%. Ten subjects completed the study. In group 4, eight of ten subjects vomited the activated charcoal/MgSO4 immediately, making statistical analysis impossible. Analysis revealed that activated charcoal/MgSO4 significantly lowered the absorption of aspirin compared with the control and ipecac-treated groups. Furthermore, ipecac significantly lowered aspirin absorption compared with the control group. We conclude that activated charcoal/MgSO4 used alone is superior to the other treatment modalities at inhibiting the absorption of multiple aspirin tablets.

(Arch Intern Med 1984;144:48-52)



Author Affiliations

From the Departments of Pharmacy Practice, University of Illinois at Chicago (Dr Curtis), Rutgers University, Piscataway, NJ (Dr Barone), and University of Utah, Salt Lake City (Dr Giacona).


Footnotes

Accepted for publication July 21, 1983.

Reprint requests to 50 N Medical Dr, Room A050, Salt Lake City, Utah 84132 (Dr Giacona).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose
Dargan et al.
Emerg. Med. J. 2002;19:206-209.
ABSTRACT | FULL TEXT  

Drug Poisoning and Overdose for the Health Professional: Review of Select Over-the-Counter (OTC) and Prescription Medications
Laven and Oller
Journal of Pharmacy Practice 2000;13:37-81.
ABSTRACT  

Multiple-Dose Charcoal and Whole-Bowel Irrigation Do Not Increase Clearance of Absorbed Salicylate
Mayer et al.
Arch Intern Med 1992;152:393-396.
ABSTRACT  

Reversible Adsorption (Desorption) of Aspirin From Activated Charcoal
Filippone et al.
Arch Intern Med 1987;147:1390-1392.
ABSTRACT  

Whole Bowel Irrigation as a Decontamination Procedure After Acute Drug Overdose
Tenenbein et al.
Arch Intern Med 1987;147:905-907.
ABSTRACT  

Treatment of Paraquat Poisoning in Man: Methods to Prevent Absorption
Meredith and Vale
Hum Exp Toxicol 1987;6:49-55.
ABSTRACT  

Expanded Role of Charcoal Therapy in the Poisoned and Overdosed Patient
Park et al.
Arch Intern Med 1986;146:969-973.
ABSTRACT  

Activated Charcoal Reborn: Progress in Poison Management
Spyker
Arch Intern Med 1985;145:43-44.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.